With nothing to soften the blow when commodity prices fall, their revenues and earnings will take a hit. And investors won't ...

That question was on the minds of millions of investors on Thursday, as the Nasdaq Composite ( ^IXIC -5.52%) had one of its ...

Palantir stock is selling off despite another round of strong quarterly results. Where does the stock go from here?

Vertex Pharmaceuticals' moat in cystic fibrosis remains nearly impregnable. The company’s diversification efforts are slowly ...

When the stock market is volatile, some caution in investing might be warranted. The market is led by a handful of AI stocks ...

Another growth driver will be AI coding, thanks to SpaceX's recent acquisition of Cursor. Cursor is essentially a workflow ...

Kimberly-Clark maintains a defensive position with essential household brands and steady cash generation. Lululemon Athletica ...

Portfolio sales are being weighed against park-level returns, so the bigger question is whether capital discipline can ...

Its share buyback plan rests on cash from refranchising clubs, a tension the 8% revenue outlook alone does not resolve.

Management's 2027 portfolio plan is still unproven, and the question is whether pricing discipline can lift a 46.8% gross ...

The world's most valuable company has seen its stock price plummet about 15% since Oct. 6, down to $203 per share as of Nov.

Management is betting on pricing changes and buyer behavior over near-term customer counts, a trade-off that likely defines ...